Effect of progranulin on the expression of nuclear factor-kappa B in lung tissue of mice with acute lung injury

Peng Qiaozhi, Xu Fang, Lin Shihui

PDF(2361 KB)
PDF(2361 KB)
Journal of Chongqing Medical University ›› 2024, Vol. 49 ›› Issue (04) : 395-400. DOI: 10.13406/j.cnki.cyxb.003481
Basic research

Effect of progranulin on the expression of nuclear factor-kappa B in lung tissue of mice with acute lung injury

Author information +
History +

Abstract

Objective To investigate the effect and possible mechanisms of progranulin(PGRN) on acute lung injury(ALI) in sepsis. Methods C57BL/6 mice were randomly divided into normal control group(Control group),acute lung injury group(CLP group),and PGRN treatment group(CLP+PGRN group). Cecal ligation and puncture(CLP) was used to establish a mouse model of septic ALI,and the mice in the CLP+PGRN group were given intraperitoneal injection of PGRN at half an hour after CLP treatment. The mice were anesthetized and sacrificed after 24 hours,and lung tissue was collected for HE staining to observe the pathological damage of lungs; the TUNEL method was used to observe cell apoptosis in lungs;immunofluorescent staining was used to measure the level of nuclear factor-kappa B(NF-κB) in lung tissue;Western blot was used to measure the expression levels of NF-κB,total p65,and phosphorylated p65(p-p65),and RT-qPCR was used to measure the levels of NF-κB and inflammatory factors. Results Compared with the Control group,the CLP group and the CLP+PGRN group had aggravated lung injury and significant increases in proinflammatory cytokines,cell apoptosis in lung tissue,and the expression levels of NF-κB,p65,and p-p65. Compared with the CLP group,the CLP+PGRN group had alleviation of lung injury and apoptosis,a reduction in proinflammatory cytokines,increases in anti-inflammatory cytokines,and significant reductions in the expression levels of NF-κB,p65,and p-p65. Conclusion PGRN can alleviate ALI in mice with sepsis,possibly by inhibiting the expression of NF-κB and p65 and the phosphorylation of p65.

Key words

acute respiratory distress syndrome / progranulin / nuclear factor-kappa B / p65

Cite this article

Download Citations
Peng Qiaozhi , Xu Fang , Lin Shihui. Effect of progranulin on the expression of nuclear factor-kappa B in lung tissue of mice with acute lung injury. Journal of Chongqing Medical University. 2024, 49(04): 395-400 https://doi.org/10.13406/j.cnki.cyxb.003481

References

1
Villar J Szakmany T Grasselli G,et al. Redefining ARDS:a paradigm shift[J]. Crit Care202327(1):416.
2
Schmidt M Hajage D Lebreton G,et al. Prone positioning during extracorporeal membrane oxygenation in patients with severe ARDS:the PRONECMO randomized clinical trial[J]. JAMA. 2023;330(24):2343-2353.
3
Attaway AH Scheraga RG Bhimraj A,et al. Severe covid-19 pneumonia:pathogenesis and clinical management[J]. BMJ2021372:n436.
4
Wilson JG Calfee CS. ARDS subphenotypes:understanding a heterogeneous syndrome[J]. Crit Care202024(1):102.
5
Saeedi-Boroujeni A Purrahman D Shojaeian A,et al. Progranulin (PGRN) as a regulator of inflammation and a critical factor in the immunopathogenesis of cardiovascular diseases[J]. J Inflamm202320(1):1.
6
Xie W Lu QC Wang KL,et al. miR-34b-5p inhibition attenuates lung inflammation and apoptosis in an LPS-induced acute lung injury mouse model by targeting progranulin[J]. J Cell Physiol2018233(9):6615-6631.
7
Mitchell S Vargas J Hoffmann A. Signaling via the NFκB system[J]. Wiley Interdiscip Rev Syst Biol Med20168(3):227-241.
8
Min Y Kim MJ Lee SN,et al. Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation[J]. Autophagy201814(8):1347-1358.
9
Mikawa K Nishina K Takao Y,et al. ONO-1714,a nitric oxide synthase inhibitor,attenuates endotoxin-induced acute lung injury in rabbits[J]. Anesth Analg200397(6):1751-1755.
10
Luyt CE Bouadma L Morris AC,et al. Pulmonary infections complicating ARDS[J]. Intensive Care Med2020,46(12):2168-2183.
11
Asselah T Durantel D Pasmant E,et al. COVID-19:discovery,diagnostics and drug development[J]. J Hepatol202174(1):168-184.
12
Meyer NJ Gattinoni L Calfee CS. Acute respiratory distress syndrome[J]. Lancet2021398(10300):622-637.
13
Lin SH Wu H Wang CJ,et al. Regulatory T cells and acute lung injury:cytokines,uncontrolled inflammation,and therapeutic implications[J]. Front Immunol20189:1545.
14
Huang GW Jian JL Liu CJ. Progranulinopathy:a diverse realm of disorders linked to progranulin imbalances[J]. Cytokine Growth Factor Rev2023:S1359-S6101(23)00078-3.
15
Purrahman D Shojaeian A Poniatowski ŁA,et al. The role of progranulin (PGRN) in the pathogenesis of ischemic stroke[J]. Cell Mol Neurobiol202343(7):3435-3447.
16
Logan T Simon MJ Rana A,et al. Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic[J]. Cell2024187(6):1565-1566.
17
Liu LL Guo HM Song AM,et al. Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways[J]. BMC Immunol202021(1):32.
18
Sun RX Wang D Song YX,et al. Granulin as an important immune molecule involved in lamprey tissue repair and regeneration by promoting cell proliferation and migration[J]. Cell Mol Biol Lett202227(1):64.
19
Wei J Hettinghouse A Liu C. The role of progranulin in arthritis[J]. Ann N Y Acad Sci20161383(1):5-20.
20
Boylan MA Pincetic A Romano G,et al. Targeting progranulin as an immuno-neurology therapeutic approach[J]. Int J Mol Sci202324(21):15946.
21
Yan D Zhang YN Huang YH,et al. Progranulin facilitates corneal repair through dual mechanisms of inflammation suppression and regeneration promotion[J]. Inflammation2024:69-85.
22
Purrahman D Mahmoudian-Sani MR Saki N,et al. Involvement of progranulin (PGRN) in the pathogenesis and prognosis of breast cancer[J]. Cytokine2022151:155803.
23
Jian JL Li GF Hettinghouse A,et al. Progranulin:a key player in autoimmune diseases[J]. Cytokine2018101:48-55.
24
Zhao MY Wang MZ Chen XX,et al. Targeting progranulin alleviated silica particles-induced pulmonary inflammation and fibrosis via decreasing Il-6 and Tgf-β1/Smad[J]. J Hazard Mater2024465:133199.
25
Du H Wong MY Zhang TT,et al. A multifaceted role of progranulin in regulating amyloid-beta dynamics and responses[J]. Life Sci Alliance20214(7):e202000874.
26
Chen SC Bie MJ Wang XW,et al. PGRN exacerbates the progression of non-small cell lung cancer via PI3K/AKT/Bcl-2 antiapoptotic signaling[J]. Genes Dis20229(6):1650-1661.
27
Efferth T Oesch F. The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases[J]. Med Res Rev202141(6):3023-3061.
28
Barrat FJ Crow MK Ivashkiv LB. Interferon target-gene expression and epigenomic signatures in health and disease[J]. Nat Immunol201920(12):1574-1583.
29
Schlein L.J. Thamm D.H.. NF-κB activation in canine cancer[J]. Veterinary Pathology 59(5) (2022) 724-732.
30
Zusso M Lunardi V Franceschini D,et al. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-κB pathway[J]. J Neuroinflammation201916(1):148.
31
Wu YQ Wang YH Liu B,et al. SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-κB p65 translocation[J]. Respir Res202021(1):130.
32
Devi K Soni S Tripathi V,et al. Ethanolic Extract of Tridax procumbens mitigates pulmonary inflammation via inhibition of NF-κB/p65/ERK mediated signalling in an allergic asthma model[J]. Phytomedicine02299:154008.
33
Cheng YM Liu B Qian H,et al. BAY11-7082 inhibits the expression of tissue factor and plasminogen activator inhibitor-1 in type-Ⅱ alveolar epithelial cells following TNF-α stimulation via the NF-κB pathway[J]. Exp Ther Med202121(2):177.
34
Zhou J Peng ZL Wang J. Trelagliptin alleviates lipopolysaccharide(LPS)-induced inflammation and oxidative stress in acute lung injury mice[J]. Inflammation202144(4):1507-1517.
35
Chen H Zhang W Luo S,et al. Lead exposure induces neuronal apoptosis via NFκB p65/RBBP4/Survivin signaling pathway[J]. Toxicology2023499:153654.

Comments

PDF(2361 KB)

Accesses

Citation

Detail

Sections
Recommended

/